Hydron;(E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine;chloride
(OLUNPKFOFGZHRT-YGCVIUNWSA-N)
Structure
- SMILES
- CN(Cc1cccc2c1cccc2)C/C=C/c1ccccc1.Cl
- Molecular Formula:
- C21H22ClN
- Molecular Weight:
- 323.859
- Log P:
- 5.7870
- Hydrogen Bond Acceptor:
- 1
- Hydrogen Bond Donor:
- 1
- TPSA:
- 3.24
- CAS Number(s):
- 65473-14-5
Synonym(s)
1.
Hydron;(E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine;chloride
2.
Naftifine hydrochloride
External Link(s)
| PubChem Compound | 5281098 67108133 |
| ChEBI | 7452 |
| CHEMBL | CHEMBL1200493 |
| KEGG | cpd:C08072 dr:D00883 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Erythema | FAERS: 9 | US FAERS | |
| 2 | Hypersensitivity | FAERS: 7 | US FAERS | |
| 3 | Pruritus | FAERS: 6 | US FAERS | |
| 4 | Burning sensation | FAERS: 4 | US FAERS | |
| 5 | Application site erythema | FAERS: 3 | US FAERS | |
| 6 | Application site pain | FAERS: 3 | US FAERS | |
| 7 | Drug ineffective | FAERS: 3 | US FAERS | |
| 8 | Application site dryness | FAERS: 2 | US FAERS | |
| 9 | Application site papules | FAERS: 2 | US FAERS | |
| 10 | Application site reaction | FAERS: 2 | US FAERS | |
| 11 | Drug effect incomplete | FAERS: 2 | US FAERS | |
| 12 | Dry skin | FAERS: 2 | US FAERS | |
| 13 | Peripheral swelling | FAERS: 2 | US FAERS | |
| 14 | Acne | FAERS: 1 | US FAERS | |
| 15 | Anorgasmia | FAERS: 1 | US FAERS | |
| 16 | Application site discharge | FAERS: 1 | US FAERS | |
| 17 | Application site erosion | FAERS: 1 | US FAERS | |
| 18 | Application site irritation | FAERS: 1 | US FAERS | |
| 19 | Application site pruritus | FAERS: 1 | US FAERS | |
| 20 | Application site rash | FAERS: 1 | US FAERS | |
| 21 | Application site vesicles | FAERS: 1 | US FAERS | |
| 22 | Bronchitis | FAERS: 1 | US FAERS | |
| 23 | Burning feet syndrome | FAERS: 1 | US FAERS | |
| 24 | Discomfort | FAERS: 1 | US FAERS | |
| 25 | Drug administered at inappropriate site | FAERS: 1 | US FAERS | |
| 26 | Eczema | FAERS: 1 | US FAERS | |
| 27 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 28 | Eye irritation | FAERS: 1 | US FAERS | |
| 29 | Food Allergy | FAERS: 1 | US FAERS | |
| 30 | Headache | FAERS: 1 | US FAERS | |
| 31 | Inflammation | FAERS: 1 | US FAERS | |
| 32 | Influenza | FAERS: 1 | US FAERS | |
| 33 | Pain | FAERS: 1 | US FAERS | |
| 34 | Product dose omission | FAERS: 1 | US FAERS | |
| 35 | Rhinalgia | FAERS: 1 | US FAERS | |
| 36 | Skin irritation | FAERS: 1 | US FAERS | |
| 37 | Skin lesion | FAERS: 1 | US FAERS | |
| 38 | Swelling | FAERS: 1 | US FAERS | |
| 39 | Wound Complication | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.